Literature DB >> 27693168

[Cardiac permanent pacemaker after transcatheter aortic valve implantation: A predictive and scientific review].

C Moini1, B Sidia2, D Poindron3, L Fiorina3, A Farge4, W Amara5, M El Issa6.   

Abstract

Transcatheter aortic valve implantation (TAVI) is nowadays a worldwide technique in the field of treating aortic stenosis. One of the main side effects linked to the technique are mostly attached to rhythm disturbances, such as atrioventricular (AV) and intraventricular blocks. Consequently, a pacemaker implantation is often required. That implantation rate is estimated between 8 and 30%, depending on the valve chosen. Thanks to main meta analysis on the subject, it has been managed to isolate the following risks factors for AV block development: preoperative right bundle branch block (RBBB: the most powerful element), complete AV block during the procedure, male gender, a so-called porcelain aorta, the absence of previous valvular surgery, the aortic annulus size (i.e when that size is inferior to the valve's one) and the QRS duration after the procedure (the superior threshold has been set at 128ms for the Corevalve). The currently recommendations advice to implant a pacemaker are as followed: high grade AV block (in the main studies, the implantation occurs within the 5 days after the TAVI), complete and transient AV block during the TAVI, second degree AV block and RBBB associated with first degree AV block. Our article aims to review the arrhythmic issues of TAVI.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Conductive disturbances; CoreValve(®); Facteurs prédictifs; Pacemaker; Predictive factors; TAVI; Troubles conductifs; Valve Edwards Sapien(®)

Mesh:

Year:  2016        PMID: 27693168     DOI: 10.1016/j.ancard.2016.09.003

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  1 in total

1.  Transient left anterior and septal fascicular blocks after self-expandable percutaneous transcatheter aortic valve implantation.

Authors:  Andrés R Pérez-Riera; Raimundo Barbosa-Barros; Mariana F Cabral de Oliveira; Rodrigo Daminello-Raimundo; Luiz C de Abreu; Kjell Nikus
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-04-19       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.